mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.06 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.1 |
0.06 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.06 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.06 |